Top Markets
Coin of the day
Original BioMedicals Co., Ltd. Original BioMedicals Co., Ltd.

Original BioMedicals Co., Ltd.

6483
Clasificación en acciones #27899
Original BioMedicals Co., Ltd. is a biotechnology company focused on creating... Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.
Precio por acción
$0.44677634
Capitalización bursátil
$29.85M
Cambio (1 día)
0.36%
Cambio (1 año)
-2.97%
País
TW
Comercio Original BioMedicals Co., Ltd. (6483)

Categoría

Ratio P/B de Original BioMedicals Co., Ltd. (6483)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Original BioMedicals Co., Ltd., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Original BioMedicals Co., Ltd. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras